Clinical studies recruiting near Bristol

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-39007, Bristol, UK · Colorado Prevention Center · NCT06024746 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Bristol Hospital- Site Number : 8400017 · Sanofi · NCT06867094 GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis
NA · North Bristol NHS Trust · Imperial College London · NCT06166537 A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · Bristol Royal Hospital for Children · University of Birmingham · NCT05991388 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Southmead Hospital ( Site 3010) · Merck Sharp & Dohme LLC · NCT06136559 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · University Hospitals Bristol NHS Foundation Trust ( Site 260 · Merck Sharp & Dohme LLC · NCT06393374 Methods of T Cell Depletion Trial (MoTD)
Phase 2 · Bristol Haematology and Oncology Centre · University of Birmingham · NCT04888741 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Bristol Royal Infirmary · Alfasigma S.p.A. · NCT06865417 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Bristol Haematology & Oncology Centre · Hoffmann-La Roche · NCT06793215 Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · University Hospitals Bristol · CellCentric Ltd. · NCT04068597 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Southmead Hospital · Amgen · NCT07037433 Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurre
Phase 4 · University of Bristol Bristol Medical School · Alimera Sciences · NCT06539481 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · University Hospitals Bristol and Weston NHS Foundation Trust · Bayer · NCT07192952 Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA · University Hospitals Bristol and Weston NHS Foundation Trust · University College, London · NCT05604963 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Southmead Hospital · Eli Lilly and Company · NCT07222332 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Southmead Hospital · Eli Lilly and Company · NCT06937086 Inari VISION Registry
Phase N/A · Southmead Hospital Bristol · Inari Medical · NCT06600542 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Bristol Haematology and Oncology Centre · Loxo Oncology, Inc. · NCT05254743 Efficacy of INM004 in Children With STEC-HUS
Phase 3 · Bristol Royal Hospital for Children · Inmunova S.A. · NCT06389474 Study on Optimal Temperature During Cardiopulmonary Bypass (THERMIC-4)
NA · University Hospitals Bristol and Weston NHS Foundation Trust · University of Leicester · NCT05996120 Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Ran
NA · Southmead Hospital, North Bristol NHS Trust · Carsten Dirksen · NCT06309238 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Southmead Hospital · Boehringer Ingelheim · NCT06531824 A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Phase 2 · Southmead Hospital - North Bristol NHS Trust · Gesynta Pharma AB · NCT07260669 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Velocity Clinical Research, Bristol · Eli Lilly and Company · NCT07353931 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06632327 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Phase 3 · Bristol Royal Hospital for Children · Eli Lilly and Company · NCT06672549 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Bristol Royal Infirmary University Hospitals · Eli Lilly and Company · NCT06338995 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Bristol Haematology and Oncology Centre ( Site 2072) · Merck Sharp & Dohme LLC · NCT06623422 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Southmead Hospital · Janssen Research & Development, LLC · NCT06319820

Look up another city

Look up another condition